City Research Online

Does the visual field improve after initiation of intraocular pressure lowering in the United Kingdom Glaucoma Treatment Study?

Reddingius, P. F., Kelly, S. R., Ometto, G. ORCID: 0000-0002-0900-4847 , Garway-Heath, D. F. & Crabb, D. P. ORCID: 0000-0001-8611-1155 (2025). Does the visual field improve after initiation of intraocular pressure lowering in the United Kingdom Glaucoma Treatment Study?. American Journal of Ophthalmology, 269, pp. 346-354. doi: 10.1016/j.ajo.2024.08.023

Abstract

Purpose
Evidence to support the hypothesis that visual field (VF) status can improve after initiation of intraocular pressure (IOP) reducing treatment is controversial. We take advantage of participant eligibility data from the United Kingdom Glaucoma Treatment Study (UKGTS) to test this hypothesis in newly diagnosed glaucomatous patients randomised to IOP lowering therapy or placebo.

Design
Multicentre, randomised, triple-masked, placebo-controlled trial.

Participants
Newly diagnosed open-angle glaucoma patients in the UKGTS with eligibility and baseline data (n = 202 and n = 205 participants from the treatment and placebo groups, respectively).

Methods
UKGTS eligibility data, including two reliable VFs (Humphrey 24-2 SITA Standard) and IOP measurements were compared to UKGTS trial baseline data acquired after allocation to treatment (topical prostaglandin analog) or placebo eye drops. Mean change in VF mean deviation (MD) and proportion of eyes that improved MD by more than different thresholds were compared across this interval in the treatment and placebo groups. Secondary analyses included stratifying the groups by level of IOP, level of VF loss and age along with pointwise analyses including change in subsets of VF locations.

Main outcome measure
Mean change in VF MD.

Results
Mean (standard deviation [SD]) time between eligibility/baseline visits and reduction in IOP was 12 (3) weeks and 4.8 (4.2) and 1.0 (3.6) mmHg for the treated and placebo eyes, respectively. Mean (SD) change in MD was almost the same for the treated (-0.03 (1.45) dB) and placebo groups (+0.08 (1.72) dB) (P=0.47). Proportion of participants with an MD improvement of 1 dB or more were similar for both groups (P=0.25). No association was found between MD improvement and magnitude of IOP lowering. Stratifying data by IOP, level of VF loss and age did not reveal any differences between the treated and placebo groups and neither did any of the pointwise VF analyses.

Conclusion
Initial short-term VF changes in the treatment and placebo arms of UKGTS were the same. In these newly diagnosed patients (non-advanced glaucoma) we found no evidence to support the hypothesis that VF status improves after initial lowering of IOP by medical therapy.

Publication Type: Article
Additional Information: This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Publisher Keywords: Glaucoma, Visual field, Intraocular pressure, Perimetry, Clinical trial
Subjects: R Medicine > RE Ophthalmology
Departments: School of Health & Psychological Sciences
School of Health & Psychological Sciences > Optometry & Visual Sciences
SWORD Depositor:
[thumbnail of 1-s2.0-S0002939424003842-main.pdf]
Preview
Text - Published Version
Available under License Creative Commons Attribution.

Download (850kB) | Preview
[thumbnail of 1-s2.0-S0002939424003842-main.pdf] Text - Accepted Version
This document is not freely accessible due to copyright restrictions.
Available under License Creative Commons: Attribution International Public License 4.0.

Export

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Downloads

Downloads per month over past year

View more statistics

Actions (login required)

Admin Login Admin Login